Summary
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Market Segment as follows:
By Type
Argatroban Powder
Argatroban Injection
By Application
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
By Company
Pfizer
SANDOZ
GlaxoSmithKline
fresenius-kabi
Eagle Pharmaceuticals
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
WEST-WARD
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Argatroban Powder
1.1.2.2 Argatroban Injection
1.1.3 Market by Application
1.1.3.1 Heparin-induced thrombocytopenia (HIT)
1.1.3.2 Percutaneous Coronary Intervention
1.1.3.3 Cerebral arterial thrombosis
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Pfizer
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 SANDOZ
6.3 GlaxoSmithKline
6.4 fresenius-kabi
6.5 Eagle Pharmaceuticals
6.6 Mitsubishi Tanabe Pharma
6.7 Teva Pharmaceutical Industries
6.8 WEST-WARD
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Argatroban Powder Market Size and CAGR 2013-2018 (Million USD)
Figure Argatroban Powder Market Size and CAGR 2013-2018 (Volume)
Figure Argatroban Powder Market Forecast and CAGR 2019-2025 (Million USD)
Figure Argatroban Powder Market Forecast and CAGR 2019-2025 (Volume)
Figure Argatroban Injection Market Size and CAGR 2013-2018 (Million USD)
Figure Argatroban Injection Market Size and CAGR 2013-2018 (Volume)
Figure Argatroban Injection Market Forecast and CAGR 2019-2025 (Million USD)
Figure Argatroban Injection Market Forecast and CAGR 2019-2025 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2018 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2019-2025 (Volume)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Million USD)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2018 (Volume)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Million USD)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2019-2025 (Volume)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Million USD)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2018 (Volume)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Million USD)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure Global Argatroban Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Argatroban Market Forecast and CAGR 2019-2025 (Volume)
Figure China Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure China Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure China Argatroban Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Argatroban Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Argatroban SWOT List
Figure Argatroban Porter's Five Forces
